Inverse benefit law
||This article needs more medical references for verification or relies too heavily on primary sources. (January 2015)|
The inverse benefit law states that the more a new drug is marketed, the worse it is for patients. More precisely, the ratio of benefits to harms among patients taking new drugs tends to vary inversely with how extensively a drug is marketed. Two Americans, Howard Brody and Donald Light, have defined the inverse benefit law, inspired by Tudor Hart's inverse care law.
- Disease mongering
- Health policy
- Inverse care law
- Patient safety
- Pharmaceutical marketing
- Public health
- Quaternary prevention
- Brody H, Light DW. The inverse benefit law: how drug marketing undermines patient safety and public health. Am J Public Health. 2011; 101(3):399-404.[dead link][dead link]
- Light DW (Editor). The Risks of Prescription Drugs. New York: Columbia University Press; 2010.
- Evans I, Thornton H, Chalmers I. Testing Treatments: Better Research for Better Healthcare. London: Pinter & Martin Ltd; 2010.